Tenaya SVP sells shares for RSU tax cover

Tenaya Therapeutics, Inc. SVP of Finance Tomohiro Higa reported an open-market sale of 1,485 shares of common stock on May 18, 2026 at an average price of $0.7932 per share.

Rhea-AI Filing Summary

Tenaya Therapeutics, Inc. SVP of Finance Tomohiro Higa reported an open-market sale of 1,485 shares of common stock on May 18, 2026 at an average price of $0.7932 per share. According to the disclosure, these shares were sold to cover tax withholding obligations tied to the vesting of restricted stock units granted on August 15, 2024.

After this transaction, Higa directly holds 118,267 shares of Tenaya common stock. This figure includes 67,938 shares that will be issued to him upon future vesting of restricted stock units, indicating that the sale represents a small portion of his overall equity exposure.

Insider Trade Summary

Net Seller: 1,485 shares

Net Sell 1 txn

Insider Higa Tomohiro

Role SVP, Finance

Sold 1,485 shs ($1K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,485	$0.7932	$1K

Holdings After Transaction: Common Stock — 118,267 shares (Direct)

Footnotes (2)

1. F1. Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on August 15, 2024.
2. F2. Includes 67,938 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

Key Figures

Shares sold: 1,485 shares Sale price per share: $0.7932 per share Shares held after transaction: 118,267 shares +2 more

5 metrics

Shares sold 1,485 shares Open-market sale on May 18, 2026

Sale price per share $0.7932 per share Average price for the 1,485 shares sold

Shares held after transaction 118,267 shares Direct holdings following the reported sale

RSU-linked shares included 67,938 shares Will be issued upon vesting of restricted stock units

RSU grant date August 15, 2024 Restricted stock units whose vesting triggered tax obligations

Key Terms

restricted stock units, tax withholding obligations, open-market sale, common stock

4 terms

restricted stock units financial

"vesting of restricted stock units awarded on August 15, 2024"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"Shares sold to cover tax withholding obligations in connection with the vesting"

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

common stock financial

"Includes 67,938 shares of Tenaya Therapeutics, Inc. common stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Tenaya Therapeutics (TNYA) report for Tomohiro Higa?

Tenaya Therapeutics reported that SVP, Finance Tomohiro Higa sold 1,485 shares of common stock. The shares were sold in an open-market transaction primarily to cover tax withholding obligations related to restricted stock units that recently vested.

At what price did the Tenaya Therapeutics (TNYA) SVP sell his shares?

The 1,485 Tenaya Therapeutics shares were sold at an average price of $0.7932 per share. This reflects an open-market sale executed specifically to satisfy tax withholding obligations from the vesting of previously granted restricted stock units.

Why did Tenaya Therapeutics SVP Tomohiro Higa sell 1,485 TNYA shares?

The shares were sold to cover tax withholding obligations from the vesting of restricted stock units granted on August 15, 2024. Such tax-related sales are typically mechanical events tied to equity compensation, rather than discretionary portfolio decisions.

How many Tenaya Therapeutics (TNYA) shares does Tomohiro Higa hold after the transaction?

Following the sale, Tomohiro Higa holds 118,267 shares of Tenaya common stock. This total includes 67,938 shares that will be issued upon future vesting of restricted stock units, showing a substantial remaining equity position after the tax-related sale.

Do Tomohiro Higa’s remaining Tenaya Therapeutics (TNYA) holdings include unvested RSUs?

Yes. His reported 118,267-share position includes 67,938 Tenaya shares that will be issued upon vesting of restricted stock units. These RSUs represent part of his ongoing equity compensation and contribute to his overall exposure to the company’s stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/19/2026 - 07:06 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Higa Tomohiro

(Last) (First) (Middle)

C/O TENAYA THERAPEUTICS, INC.

171 OYSTER POINT BLVD., 5TH FLOOR

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Tenaya Therapeutics, Inc. [ TNYA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Finance

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/18/2026		S(1)		1,485	D	$0.7932	118,267(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on August 15, 2024.

2. Includes 67,938 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

	/s/ Jennifer Drimmer Rokovich, Attorney-in-Fact	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)